Russell Investments Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $135M | Buy |
1,070,731
+2,894
| +0.3% | +$381K | 0.12% | 162 |
|
|
2026
Q1 | $148M | Sell |
1,067,837
-193,459
| -15% | -$27.1M | 0.16% | 123 |
|
|
2025
Q4 | $155M | Buy |
1,261,296
+50,024
| +4% | +$6.08M | 0.17% | 115 |
|
|
2025
Q3 | $135M | Sell |
1,211,272
-49,215
| -4% | -$5.59M | 0.15% | 130 |
|
|
2025
Q2 | $140M | Buy |
1,260,487
+10,620
| +0.8% | +$1.13M | 0.18% | 112 |
|
|
2025
Q1 | $140M | Buy |
1,249,867
+250,538
| +25% | +$25.9M | 0.19% | 103 |
|
|
2024
Q4 | $92.3M | Buy |
999,329
+70,214
| +8% | +$6.32M | 0.13% | 156 |
|
|
2024
Q3 | $77.9M | Sell |
929,115
-145,756
| -14% | -$11.1M | 0.11% | 199 |
|
|
2024
Q2 | $73.8M | Buy |
1,074,871
+47,891
| +5% | +$3.2M | 0.12% | 178 |
|
|
2024
Q1 | $75.2M | Sell |
1,026,980
-55,922
| -5% | -$4.3M | 0.12% | 182 |
|
|
2023
Q4 | $87.7M | Sell |
1,082,902
-209,199
| -16% | -$16.3M | 0.16% | 135 |
|
|
2023
Q3 | $96.9M | Buy |
1,292,101
+45,984
| +4% | +$3.54M | 0.19% | 107 |
|
|
2023
Q2 | $95.9M | Sell |
1,246,117
-234,711
| -16% | -$18.7M | 0.19% | 106 |
|
|
2023
Q1 | $122M | Sell |
1,480,828
-9,457
| -0.6% | -$783K | 0.24% | 82 |
|
|
2022
Q4 | $128M | Sell |
1,490,285
-287,801
| -16% | -$22.8M | 0.26% | 70 |
|
|
2022
Q3 | $110M | Buy |
1,778,086
+44,171
| +3% | +$2.79M | 0.24% | 77 |
|
|
2022
Q2 | $107M | Buy |
1,733,915
+203,842
| +13% | +$12.6M | 0.22% | 86 |
|
|
2022
Q1 | $91M | Buy |
1,530,073
+447,449
| +41% | +$28.6M | 0.16% | 150 |
|
|
2021
Q4 | $78.7M | Sell |
1,082,624
-21,495
| -2% | -$1.48M | 0.13% | 190 |
|
|
2021
Q3 | $77.5M | Sell |
1,104,119
-127,745
| -10% | -$8.97M | 0.13% | 175 |
|
|
2021
Q2 | $84.6M | Buy |
1,231,864
+50,431
| +4% | +$3.37M | 0.14% | 159 |
|
|
2021
Q1 | $76.6M | Sell |
1,181,433
-191,659
| -14% | -$12.4M | 0.14% | 163 |
|
|
2020
Q4 | $79.1M | Buy |
1,373,092
+12,570
| +0.9% | +$758K | 0.16% | 140 |
|
|
2020
Q3 | $85.4M | Buy |
1,360,522
+216,712
| +19% | +$15M | 0.18% | 114 |
|
|
2020
Q2 | $86.9M | Sell |
1,143,810
-1,934
| -0.2% | -$148K | 0.19% | 107 |
|
|
2020
Q1 | $86.1M | Sell |
1,145,744
-1,349,280
| -54% | -$93.2M | 0.22% | 93 |
|
|
2019
Q4 | $162M | Buy |
2,495,024
+11,814
| +0.5% | +$769K | 0.3% | 52 |
|
|
2019
Q3 | $157M | Buy |
2,483,210
+125,993
| +5% | +$8.24M | 0.3% | 51 |
|
|
2019
Q2 | $159M | Buy |
2,357,217
+120,030
| +5% | +$7.9M | 0.3% | 56 |
|
|
2019
Q1 | $144M | Buy |
2,237,187
+255,632
| +13% | +$17M | 0.27% | 69 |
|
|
2018
Q4 | $123M | Buy |
1,981,555
+6,785
| +0.3% | +$474K | 0.28% | 65 |
|
|
2018
Q3 | $152M | Buy |
1,974,770
+95,171
| +5% | +$7.19M | 0.29% | 61 |
|
|
2018
Q2 | $133M | Sell |
1,879,599
-168,881
| -8% | -$11.9M | 0.28% | 59 |
|
|
2018
Q1 | $154M | Sell |
2,048,480
-312,699
| -13% | -$24.9M | 0.26% | 66 |
|
|
2017
Q4 | $171M | Buy |
2,361,179
+912,621
| +63% | +$69.3M | 0.29% | 60 |
|
|
2017
Q3 | $117M | Buy |
1,448,558
+401,367
| +38% | +$30.7M | 0.2% | 99 |
|
|
2017
Q2 | $74.1M | Sell |
1,047,191
-67,933
| -6% | -$4.52M | 0.13% | 171 |
|
|
2017
Q1 | $75.7M | Sell |
1,115,124
-30,580
| -3% | -$2.15M | 0.14% | 166 |
|
|
2016
Q4 | $82.6M | Buy |
+1,145,704
| New | +$85.2M | 0.16% | 141 |
|
Other funds holding GILD
Russell Investments Group's GILD Position: Q2 2026 in Review
Russell Investments Group increased its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, buying an estimated $381K and bringing the position to 1,070,731 shares worth $135M. The position accounts for 0.12% of the portfolio, ranked #162.
Russell Investments Group first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $171M in Q4 2017. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Russell Investments Group held 1,070,731 shares of Gilead Sciences worth $135M as of Q2 2026.
- Russell Investments Group bought 2,894 Gilead Sciences shares in Q2 2026, an estimated $381K.
- Gilead Sciences made up 0.12% of Russell Investments Group's portfolio in Q2 2026, its #162 holding.
- Russell Investments Group first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's Gilead Sciences position peaked at $171M in Q4 2017.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.